BDH Industries Limited

Equities

BDH6

INE278D01018

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:54 2024-05-24 am EDT 5-day change 1st Jan Change
364 INR +4.99% Intraday chart for BDH Industries Limited +5.40% +66.08%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
BDH Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
BDH Industries Limited Announces Directorate Changes CI
BDH Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
BDH Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
BDH Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
BDH Industries Limited Recommends Dividend for the Year Ended March 31, 2023 CI
BDH Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
BDH Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Crisil Affirms BBB- Rating on BDH Industries' Loans; Outlook Stable MT
BDH Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
BDH Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
BDH Industries Limited Recommends Dividend for the Year Ended 31 March 2022 CI
BDH Industries Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
BDH Industries Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
BDH Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
BDH Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
BDH Industries : Crisil Affirms BBB- Rating on BDH Industries' Bank Loans; Outlook Stable MT
BDH Industries' : Net Profit Climbs in Fiscal Q4 MT
BDH Industries Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
BDH Industries Limited Recommends Dividend for the Year Ended 31 March 2021 CI
Bdh Industries Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020 CI
Bdh Industries Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020 CI
Bdh Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2020 CI
Bdh Industries Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020 CI
BDH Industries Limited Recommends Dividend for the Year Ended March 31, 2020 CI
Chart BDH Industries Limited
More charts
BDH Industries Limited is engaged in the manufacturing of pharmaceuticals. The Company is also involved in the manufacturing of therapeutic formulations covering a range of pharmaceuticals. Its products include Analgesics, Antacids, Antibacterial, Anticoagulants, Anticonvulsants, Anti-emetics, Antifungals, Antihelmentinics, Antiasthmatic, Antimalarials, Antipsychotics and others. Its products include formulations, such as Fentanyl Citrate Injection USP, KALPANJAN Forte Pain Balm, Compound Magnesium Trisilicate Tablets BP, Alcoholic Iodine Solition BP, COLD Syrup, Dicyclomine Hydrochloride Injection, and Aciclovir Cream BP. Its manufacturing facilities consist of Oncology Division and General Pharmaceuticals. Its specialty formulations include Morphine Sulphate Slow-Release Tablets 15mg, Sulfasalazine Delayed release tablets U.S.P. 500mg, Indomethacin Extended-Release Capsules U.S.P. 75 mg and others. Its manufacturing facility is located in Mumbai.
More about the company
  1. Stock Market
  2. Equities
  3. BDH6 Stock
  4. News BDH Industries Limited
  5. Crisil Affirms BBB- Rating on BDH Industries' Loans; Outlook Stable